The role of CTLA-4 in TREG function is of relevance to cancer immunotherapy, where inhibiting TREGs has been shown to improve anti-tumour immune responses and prognosis both in animal models and in clinical studies. This evidence concerns the gene CTLA4 and neoplasm.